Cargando…
Design, Synthesis and Pharmacological Evaluation of Novel Conformationally Restricted N-arylpiperazine Derivatives Characterized as D(2)/D(3) Receptor Ligands, Candidates for the Treatment of Neurodegenerative Diseases
Most neurodegenerative diseases are multifactorial, and the discovery of several molecular mechanisms related to their pathogenesis is constantly advancing. Dopamine and dopaminergic receptor subtypes are involved in the pathophysiology of several neurological disorders, such as schizophrenia, depre...
Autores principales: | da Silva Cunha, Thayssa Tavares, Silva, Rafaela Ribeiro, Rodrigues, Daniel Alencar, de Sena Murteira Pinheiro, Pedro, Kronenberger, Thales, Sant’Anna, Carlos Maurício R., Noël, François, Fraga, Carlos Alberto Manssour |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405847/ https://www.ncbi.nlm.nih.gov/pubmed/36009006 http://dx.doi.org/10.3390/biom12081112 |
Ejemplares similares
-
The Magic Methyl and Its Tricks in Drug Discovery and Development
por: Pinheiro, Pedro de Sena Murteira, et al.
Publicado: (2023) -
Methyl Effect on
the Metabolism, Chemical Stability,
and Permeability Profile of Bioactive N-Sulfonylhydrazones
por: Guedes, Jéssica de Siqueira, et al.
Publicado: (2022) -
Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases?
por: Viegas, Claudio, et al.
Publicado: (2020) -
Correction: Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D(3) receptor agonists
por: Cao, Yongkai, et al.
Publicado: (2018) -
Novel Single Inhibitor of HDAC6/8 and Dual Inhibitor of PI3K/HDAC6 as Potential Alternative Treatments for Prostate Cancer
por: Guerra, Fabiana Sélos, et al.
Publicado: (2021)